RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Return
24.59%
This Quarter Return
+0.65%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$1.97B
Cap. Flow
% of AUM
-2.66%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
93
Increased
1,360
Reduced
1,565
Closed
46
Top Buys
| 1 |
Moderna
MRNA
|
+$63.3M |
| 2 |
Analog Devices
ADI
|
+$46M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$36.7M |
| 4 |
Match Group
MTCH
|
+$29M |
| 5 |
Tesla
TSLA
|
+$20.3M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$86.6M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$77.4M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$76.7M |
| 4 |
Apple
AAPL
|
+$74M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$67.8M |
Sector Composition
| 1 | Technology | 23.92% |
| 2 | Financials | 14.19% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.1% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RETA
1651
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $3.06M | ﹤0.01% |
30,437
+268
| +0.9% | +$27K |
|
1652
WesBanco
WSBC
$3.03B
| $3.06M | ﹤0.01% |
89,715
+954
| +1% | +$32.5K |
|
1653
Sphere Entertainment
SPHR
$2.1B
| $3.05M | ﹤0.01% |
41,957
+12,890
| +44% | +$937K |
|
|
MFA
1654
MFA Financial
MFA
$1.04B
| $3.05M | ﹤0.01% |
166,623
+4,350
| +3% | +$79.5K |
|
1655
Extreme Networks
EXTR
$2.95B
| $3.04M | ﹤0.01% |
308,780
-47,763
| -13% | -$470K |
|
1656
Editas Medicine
EDIT
$242M
| $3.04M | ﹤0.01% |
73,871
+1,681
| +2% | +$69.1K |
|
1657
Phreesia
PHR
$1.45B
| $3.03M | ﹤0.01% |
49,039
+11,434
| +30% | +$706K |
|
1658
Amicus Therapeutics
FOLD
$2.46B
| $3.02M | ﹤0.01% |
316,281
+7,018
| +2% | +$67K |
|
|
FOCS
1659
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $3.02M | ﹤0.01% |
57,579
+14,233
| +33% | +$745K |
|
1660
Donnelley Financial Solutions
DFIN
$1.5B
| $3.01M | ﹤0.01% |
86,988
-11,964
| -12% | -$414K |
|
1661
Atea Pharmaceuticals
AVIR
$249M
| $3M | ﹤0.01% |
85,692
+3,596
| +4% | +$126K |
|
1662
Calix
CALX
$4.01B
| $3M | ﹤0.01% |
60,750
+2,037
| +3% | +$101K |
|
1663
Scholastic
SCHL
$691M
| $3M | ﹤0.01% |
84,109
-13,620
| -14% | -$485K |
|
1664
Rush Enterprises Class A
RUSHA
$4.33B
| $2.99M | ﹤0.01% |
99,282
+2,685
| +3% | +$80.8K |
|
1665
Chefs' Warehouse
CHEF
$2.7B
| $2.98M | ﹤0.01% |
91,371
-11,549
| -11% | -$376K |
|
|
AXNX
1666
DELISTED
Axonics, Inc. Common Stock
AXNX
| $2.97M | ﹤0.01% |
45,693
+3,687
| +9% | +$240K |
|
1667
Hyatt Hotels
H
$13.7B
| $2.97M | ﹤0.01% |
38,564
-2,249
| -6% | -$173K |
|
1668
Shift4
FOUR
$6B
| $2.97M | ﹤0.01% |
38,335
-145
| -0.4% | -$11.2K |
|
|
SASR
1669
DELISTED
Sandy Spring Bancorp Inc
SASR
| $2.97M | ﹤0.01% |
64,821
+1,531
| +2% | +$70.1K |
|
1670
Kadant
KAI
$3.69B
| $2.97M | ﹤0.01% |
14,548
+389
| +3% | +$79.4K |
|
|
TBI
1671
Trueblue
TBI
$179M
| $2.96M | ﹤0.01% |
109,353
-13,579
| -11% | -$368K |
|
1672
Vanda Pharmaceuticals
VNDA
$266M
| $2.94M | ﹤0.01% |
171,309
-20,415
| -11% | -$350K |
|
1673
Domo
DOMO
$701M
| $2.93M | ﹤0.01% |
34,723
+2,964
| +9% | +$250K |
|
1674
CTS Corp
CTS
$1.23B
| $2.93M | ﹤0.01% |
94,796
-11,867
| -11% | -$367K |
|
|
MAXR
1675
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $2.92M | ﹤0.01% |
103,259
+1,657
| +2% | +$46.9K |
|